How to ensure Aboriginal and Torres Strait Islander peoples benefit from newborn DNA screening
This article discusses the potential for genomic newborn screening in Australia while emphasizing the need for ethical and equitable inclusion of Aboriginal and Torres Strait Islander peoples. It highlights past failures in genetic research and calls for community consultation to ensure future benefits.
Why it matters
Ensuring equitable access to medical advancements for Indigenous populations is critical for public health and addressing historical systemic injustices.
Belinda Howell/Getty How to ensure Aboriginal and Torres Strait Islander peoples benefit from newborn DNA screening Published: July 16, 2026 9:11pm EDT https://theconversation.com/how-to-ensure-aboriginal-and-torres-strait-islander-peoples-benefit-from-newborn-dna-screening-285364 https://theconversation.com/how-to-ensure-aboriginal-and-torres-strait-islander-peoples-benefit-from-newborn-dna-screening-285364 Link copied Share article Share article
Copy link Email Bluesky Facebook WhatsApp Messenger LinkedIn X (Twitter) Print article
In Australia, every newborn baby is offered a screening test for 34 serious but treatable conditions (or groups of conditions), such as cystic fibrosis and spinal muscular atrophy. The test uses a small blood sample taken from the baby’s heel. Finding these conditions early can save lives and prevent disability.
In the future, sequencing the DNA of newborns as part of a genomic newborn screening program could allow the detection of many more conditions, potentially improving the health of more children. Over time, genetic data may also help scientists better understand diseases and develop new treatments.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in